NasdaqCM - Delayed Quote USD

The Beauty Health Company (SKIN)

3.2400 +0.1800 (+5.88%)
At close: April 26 at 4:00 PM EDT
3.1500 -0.09 (-2.78%)
After hours: April 26 at 4:07 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
397,991.0000
397,991.0000
365,876.0000
260,086.0000
119,092.0000
Cost of Revenue
242,878.0000
242,878.0000
117,097.0000
81,548.0000
51,893.0000
Gross Profit
155,113.0000
155,113.0000
248,779.0000
178,538.0000
67,199.0000
Operating Expense
286,030.0000
286,030.0000
274,620.0000
218,466.0000
84,381.0000
Operating Income
-130,917.0000
-130,917.0000
-25,841.0000
-39,928.0000
-17,182.0000
Net Non Operating Interest Income Expense
9,524.0000
9,524.0000
-4,217.0000
-11,738.0000
-21,275.0000
Other Income Expense
19,504.0000
19,504.0000
75,397.0000
-328,973.0000
-26.0000
Pretax Income
-101,889.0000
-101,889.0000
45,339.0000
-380,639.0000
-38,483.0000
Tax Provision
-1,773.0000
-1,773.0000
1,115.0000
-1,875.0000
-9,308.0000
Net Income Common Stockholders
-100,116.0000
-100,116.0000
44,224.0000
-378,764.0000
-29,175.0000
Average Dilution Earnings
--
--
-78,343.0000
--
--
Diluted NI Available to Com Stockholders
-100,116.0000
-100,116.0000
-34,119.0000
-378,764.0000
-29,175.0000
Basic EPS
-0.76
--
0.30
-3.71
-0.23
Diluted EPS
-0.76
--
-0.23
-3.71
-0.23
Basic Average Shares
131,680.6050
--
147,554.0900
102,114.9490
125,399.9130
Diluted Average Shares
131,680.6050
--
148,506.3120
102,114.9490
125,399.9130
Total Operating Income as Reported
-130,917.0000
-130,917.0000
-25,841.0000
-39,928.0000
-17,182.0000
Total Expenses
528,908.0000
528,908.0000
391,717.0000
300,014.0000
136,274.0000
Net Income from Continuing & Discontinued Operation
-100,116.0000
-100,116.0000
44,224.0000
-378,764.0000
-29,175.0000
Normalized Income
-114,176.8320
-114,176.8320
-30,973.8720
-55,902.4200
-29,190.9207
Interest Income
23,173.0000
23,173.0000
9,175.0000
39.0000
--
Interest Expense
13,649.0000
13,649.0000
13,392.0000
11,777.0000
21,275.0000
Net Interest Income
9,524.0000
9,524.0000
-4,217.0000
-11,738.0000
-21,275.0000
EBIT
-88,240.0000
-88,240.0000
58,731.0000
-368,862.0000
-17,208.0000
EBITDA
-56,001.0000
-56,001.0000
80,747.0000
-351,079.0000
-2,807.0000
Reconciled Cost of Revenue
242,878.0000
242,878.0000
117,097.0000
81,548.0000
51,893.0000
Reconciled Depreciation
32,239.0000
32,239.0000
22,016.0000
17,783.0000
14,401.0000
Net Income from Continuing Operation Net Minority Interest
-100,116.0000
-100,116.0000
44,224.0000
-378,764.0000
-29,175.0000
Total Unusual Items Excluding Goodwill
14,304.0000
14,304.0000
77,047.0000
-324,484.0000
21.0000
Total Unusual Items
14,304.0000
14,304.0000
77,047.0000
-324,484.0000
21.0000
Normalized EBITDA
-70,305.0000
-70,305.0000
3,700.0000
-26,595.0000
-2,828.0000
Tax Rate for Calcs
0.0000
0.0000
0.0000
0.0000
0.0002
Tax Effect of Unusual Items
243.1680
243.1680
1,849.1280
-1,622.4200
5.0793
12/31/2020 - 11/24/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers